General Announcement::PRESS RELEASE: IX BIOPHARMA'S XATIVA RECORDS ROBUST UPTAKE FROM INITIAL PRODUCTION RUNS IN AUSTRALIA

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Jun-2020 07:20:48
Status
New
Announcement Sub Title
PRESS RELEASE: IX BIOPHARMA'S XATIVA RECORDS ROBUST UPTAKE FROM INITIAL PRODUCTION RUNS IN AUSTRALIA
Announcement Reference
SG200630OTHRCZIZ
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

iX_Press_Release_Xativa_Sales_Update.pdf
Total size =111K